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Acute exposure to morphine after a traumatic event reduces trauma related symptoms
in humans and conditioned fear expression in male rats. We aimed to determine
whether acute administration of morphine alters consolidation of fear learning and
extinction. Male and female rats in proestrus and metaestrus (high and low ovarian
hormones respectively) underwent fear conditioning and received saline or morphine
(2.5 mg/kg s.c.). The next day they underwent extinction. Results showed increased
freezing during extinction only in the morphine metaestrus group while morphine
did not affect males or proestrus females. Recall of extinction was similar on all
groups. On a second experiment, a subset of rats conditioned during metaestrus was
administered morphine prior to extinction producing no effects. We then measured
mu opioid receptor (MOR) expression in the amygdala and periaqueductal gray
(PAG) at the end of extinction (day 2). In males and proestrus females, morphine
caused an increase in MOR in the amygdala but no in the PAG. In metaestrus
females, morphine did not change MOR expression in either structure. These data
suggests that ovarian hormones may interact with MORs in the amygdala to
transiently alter memory consolidation. Morphine given after trauma to females with
low ovarian hormones might increase the recall of fear responses, making recovery
harder.
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Studies with female and male rats regarding fear conditioning and extinction have demonstrated
that ovarian hormones modulate fear acquisition and fear extinction (Milad et al., 2009). The
higher fear observed in female in comparison to male rats during extinction recall (Milad
et al., 2009), suggests an important role in the ovarian hormones in the higher prevalence
of anxiety disorders in women (McLean et al., 2011). In the Pavlovian fear conditioning
paradigm repeated pairings of a neutral stimulus such as a tone (conditioned stimulus, CS)
with an aversive stimulus such as a mild foot shock (unconditioned stimulus, US) lead
to conditioned fear responses such as freezing. However, repeated presentations of the CS
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in the absence of the US will lead to a gradual reduction
in conditioned fear responses commonly known as extinction.
Extinction does not erase the initial CS-US association, but
is thought to form a new inhibitory memory (Pavlov, 1928;
Konorski, 1967). Deficits in fear extinction are thought to
contribute to trauma related disorders (Milad et al., 2006, 2009;
Glover et al., 2012).
Opiates like morphine, which preferentially bind to the mu
opioid receptor (MOR), are one of the first line prescriptions
for severe physical traumas, mostly used to ameliorate pain.
Despite the large usage of morphine, little is known about
the association of mental health disorders and its prescription
(Seal et al., 2012). There are several reasons to believe that
pharmacotherapy plays an important role in the development
of trauma related disorders (Bailey et al., 2013). Clinical
studies have found that acute administration of morphine has
a protective effect in Posttraumatic Stress Disorder (PTSD)
patients by preventing symptoms associated to the disorder and
the diagnosis (Bryant et al., 2009). Endogenous opioids may
be involved in certain symptoms of trauma related disorders
such as numbing, stress-induced analgesia, and dissociation
(Holbrook et al., 2010). Taking into considerations these
clinical studies, it is evident that not only they support
a role of the opioid system in trauma related disorders,
but also suggest that this system could be a therapeutic
target.
The circuitry of fear learning and extinction has been
well mapped. The basolateral amygdala (BLA) is involved in
extinction learning by stimulating inhibitory intercalated cell
mass activity to inhibit the central amygdala output neurons
(McNally and Westbrook, 2003; McNally et al., 2004; Likhtik
et al., 2008; Parsons et al., 2010). This intercalated cells are
rich in MORs (Likhtik et al., 2008). In addition, there is
evidence in humans and animal suggests that estrogens may
exert their influence on fear within the amygdala (Jasnow
et al., 2006). Estradiol also stimulates the release of endogenous
opioid peptides in the medial amygdala (Eckersell et al.,
1998). Besides the amygdala, the periaqueductal gray (PAG)
matter has an important role in the expression of freezing
behavior (Amorapanth et al., 1999). The PAG is rich in
opioid receptors (McNally, 2009) and shows sexual dimorphism
(Loyd and Murphy, 2006). Opioids within the ventrolateral
periaqueductal gray (vlPAG) are necessary for extinction
acquisition and blocking MORs in this region prevented
acquisition of extinction (McNally et al., 2005). Opioidergic
signaling in the vlPAG affects plasticity across the brain circuit
responsible for the formation of extinction memory (Parsons
et al., 2010).
The aim of this study is to elucidate if acute morphine
administration will have a stronger effect in reducing fear
conditioning in female rats as compared to male rats. We also
aim to know if the behavioral differences will depend on changes
in MOR expression in the amygdala and the PAG in response to
an opioid agonist.
We used female and male Sprague–Dawley rats (230–300 g
in weight) were paired housed under a day-night (12-h) cycle.
The rats received free access to food and water throughout the
experiment and during at least a one-week acclimation period
prior to experimentation, where the rats were handle when
performing daily vaginal smears to determine the estrous cycle
stage in female rats (Turner and Bagnara, 1971). Only rats with
regular, 4-day estrous cycles were included in the study. All
procedures were conducted in accordance with and approved by
the Ponce Health Sciences University Institutional Animal Care
and Use Committee.
Experiments 1, and 2 used four identical conditioning
chambers (25 cm × 29 cm × 28 cm, l × w × h; Coulbourn
Instruments) located inside of a sound-attenuating box (Med-
Associates). The chamber floor consists of 0.5 cm stainless steel
bars through which an electric shock is delivered. The chamber
is equipped with a speaker and a single overhead light. The
auditory tone was a 4 kHz sine wave with duration of 30 sand
an intensity of 80 dB sound pressure level (Santini et al., 2004).
We assessed the animal in the same conditioning chamber,
so the fear expressed will not be specific to the tone, but a
combination of fear to the tone and to the context. Males
and females were assessed in the same chambers; all boxes
were thoroughly cleaned with 70% ethanol between animals. All
testing sessions occurred between 9:00 AM and 1:00 PM. The
three stages of training were as follows, with the habituation
and conditioning performed on the same day: habituation;
the animals received one habituation trial (tone alone) in the
conditioning chamber with an average intertrial interval (ITI) of
2 min and conditioning; the animals received 3 tone-footshock
pairings (0.5 s 0.45 mA) in the box/context and returned to their
home cages. A group of female rats was in the proestrus stage
of the estrous cycle while another group was in the metaestrus
stage during conditioning. Twenty-four hours after conditioning,
the animals received extinction and consisted of 12 tone alone
presentations. Twenty-four hours after the conditioning a sub
group of metaestrus females receive a test that consisted of 2
tone alone presentations. Animals in each experiment group
were treated with morphine dissolved in saline (2.5 mg/kg)
or saline (0.9%) subcutaneously immediately after conditioning
or 4 h before extinction. The morphine dose was chosen as
it has been shown to be effective in reducing conditioned
fear (Rudy et al., 1999). This dose of morphine administered
acutely does not provoke withdrawal symptoms. Studies have
demonstrated that there are sex differences in rats in response
to morphine antinociceptive activity and differences between
men and women analgesia (Cicero et al., 1997; Sarton et al.,
2000). However, today is not clear the sex-differences in the
pharmacokinetics of morphine. Immediately after experiments
rats were anesthetized and decapitated, brains removed and
frozen. The amygdala and PAG were dissected based on the
atlas of Paxinos and Watson. Equal amounts of protein (100
µg) were used to identify the MORs with a rabbit polyclonal
antibody (1:1000, Immunostar). Blots were washed with TBST
and incubated in goat anti-rabbit IgG (1:1000, Santa Cruz). Bands
were visualized using Chemidoc XRS Imaging System and Image
J software (imagej.nih.gov). To perform this, we followed Ramos-
Ortolaza et al. (2010) western blot protocol. All samples were run
in duplicates with saline and morphine groups within the same
gel. Our goal was to look at changes caused by morphine and
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not absolute changes in protein, therefore data was analyzed as
a percent change in morphine-treated samples against control
group within a given gel. For a subgroup of gels we calculated
GAPDH loading control and we found a 2.3% of variability
between wells, which equally affected controls and morphine
treated animals.
Freezing time per trial was averaged in blocks of two and
converted to percentage. We used repeated measures ANOVA
considering treatment (morphine or saline), sex (female or male)
and female cycle stage (metaestrus or proestrus) as between-
subject variables. For all experiments, the significance level
was set at p < 0.05. Significant interactions were examined
using Tukey’s post hoc comparisons. The western blot was
analyzed using one sample t-test against baseline (100%) for
differences against saline control group for each sex group.
Differences between sexes for morphine groups were analyzed
using ANOVA.
Behavioral results show that for the experiment 1,
and 2 when morphine (2.5 mg/kg) or saline (0.9%)
where administered subcutaneously immediately after fear
conditioning (Figures 1A–D) or 4 h prior to extinction
(Figures 1E,F) there were no statistical differences in the
levels of conditioned freezing between groups designated
to receive saline or morphine; metaestrus (F(1,27) = 0.412,
p > 0.05), proestrus (F(1,23) = 0.009, p > 0.05) and males
(F(1,28) = 2.12, p > 0.05; Figure 1). However, extinction results
showed that administration of acute morphine immediately after
conditioning caused an increased level of conditioned freezing in
the group conditioned during metaestrus compared to controls
(F(1,27) = 25.41, p < 0.01; Figure 1B). No significant differences
were observed in the extinction session for males (F(1,28) = 1.35,
p > 0.05) or in female rats conditioned during proestrus
(F(1,23) = 0.74, p > 0.05; Figures 1C,D). To further examine
our finding in the metaestrus conditioned group, we selected a
separate set of animals that was tested for freezing behavior 24 h
after fear extinction (Day 3). This test consisted of two tone-
alone presentations. No effects were observed on day 3 for female
rats conditioned during metaestrus (F(1,11) = 0.63, p> 0.05) (not
shown), thus they remembered the extinction from previous day.
We further analyzed whether the deficit in extinction could be
associated with the stage of the cycle alone during extinction (day
2). Most rats (82%) injected with morphine and conditioned
during proestrus switched to estrus/metaestrus stages. On
the other hand, 79% the animals that were conditioned in
metaestrus and treated with morphine stayed in metaestrus
and/or switched to diestrus II. Thus, when morphine and saline
groups were re-analyzed considering the stage of the cycle at
the extinction phase, all rats that receive morphine and were
in metaestrus/diestrus II still showed increased fear on Day
2 compared to saline controls. On experiment 2, additional
group of metaestrus female rats were given morphine (2.5
mg/kg s.c.) or saline (0.9%) 4 h before extinction (Figure 1E).
They were then subjected to a two tone-alone test on Day 3.
There were no differences in freezing behavior between groups
that received saline or morphine; conditioning (F(1,12) = 0.011,
p> 0.05), extinction (F(1,12) = 0.47, p> 0.05; Figure 1F) and test
(F(1,12) = 0.36, p< 0.05; not shown).
To quantify how MOR expression was altered in response to
morphine, we dissected the amygdala and PAG of the females
and male rats from experiment 1, right after the end of the
extinction session on Day 2. Western blot results showed that
morphine administration tomale rats increasedMOR expression
in the amygdala (F(1,4) = 3.323, p < 0.05; Figure 2A), but
did not affect MOR expression in the PAG (F(1,4) = 0.640,
p> 0.05; Figure 2A). Like in the males, morphine administration
increased MOR expression in the amygdala of the proestrus
female rats (F(1,4) = 5.165, p < 0.05) and did not affect MOR
expression in the PAG (F(1,4) = 0.239, p > 0.05; Figure 2B).
In contrast, morphine administration to metaestrus female rats
did not affect MOR expression in the amygdala (F(1,4) = 0.335,
p> 0.05) or the PAG (F(1,4) = 0.065, p> 0.05; Figure 2C).
The data gathered in this study show a transient over
expression of fear memories in female rats fear conditioned
and treated with morphine during the metaestrus stage of the
estrous cycle. However, there was no significant difference in the
recall of extinction memory on metaestrus females suggesting
a transient effect of morphine shortly after its administration.
Interestingly, when treating the metaestrus rats with morphine
before extinction, no effects on fear were observed. This suggests
that the effects of acute morphine in females are linked to the
events that start shortly after the trauma occurs but once the
memory has been consolidated, morphine will have no effect.
Animal studies suggest that gonadal hormones influence
extinction of conditioned fear. Milad et al. (2009) showed that
female rats during the proestrous stage of the estrus cycle
exhibited better extinction memory during extinction recall
test. Also, when estradiol and progesterone is administered
exogenously there is a facilitated extinction recall, whereas
estradiol and progesterone receptor antagonists impair it. This
suggests that gonadal hormones influence the consolidation of
extinction memory (Milad et al., 2009). It is important to point
out, that our saline animals are consistent from Milad et al.
(2009) study, since he also analyzed the cycle stage of the female
rat during conditioning and did not see differences in behavior
between groups.
Studies indicate that low ovarian hormones are associated
with higher fear expression (Milad et al., 2009; Glover et al.,
2012, 2013). In our study many rats that were in metaestrus
during conditioning continued in the same cycle stage or
entered in diestrus II during extinction. We found that the
cycle alone cannot explain the over expression of fear because
it is not reduced when only the rats that transitioned out
of the metaestrus/diestrus stage during the extinction phase
were analized. This suggests that the higher fear responses
observed during extinction is most likely due to the interaction of
morphine with the low estrogen cycle stage during conditioning
and not due to the cycle stage during extinction. The fact that
a single dose of morphine produced a transient over expression
of fear memories in metaestrus when administered immediately
after conditioning but not before extinction, supports that
morphine’s effect is related to memory processes that occur
immediately after the trauma. This suggests that ovarian
hormones and morphine interact to alter fear memory, when
morphine is given close to the trauma event. However, once
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FIGURE 1 | Percent freezing to the tone in males, proestrus and
metaestrus female rats shown in blocks of two trials. Acute morphine
immediately after conditioning resulted in an increased level of conditioned
freezing in the metaestrus group compare to controls and acute morphine 24 h
after conditioning had no significant effect in extinction learning in metaestrus
female rats. (A) Experimental timeline. (B) Post-training injections of morphine
given after the metaestrus stage had no effect on extinction, but over
expression of conditioned fear (morphine n = 14, saline = 14). (C) Post-training
injections of morphine given during the proestrus stage had no effect either in
the consolidation of fear conditioning or within session extinction (morphine
n = 13, saline n = 14). (D) Post-training injections of morphine had no effect
either in the consolidation of fear conditioning or within session extinction in
male rats (morphine n = 15, saline n = 14). (E) Experimental timeline. (F)
Pre-extintion injections of morphine given after the metaestrus stage had no
effect either in the consolidation of fear conditioning or extinction (morphine
n = 8, saline n = 6).
morphine is no longer present, animals recover and are able
to show fear responses comparable to the animals that did not
receive morphine.
Animal studies have examined the effects of acute morphine
on male rats, on various fear conditioning behavioral protocols.
Glover and Davis (2008) study demonstrated that morphine
facilitates extinction in male rats exposed to fear potentiated
startle. Although one of the morphine doses they used is the
one we used in our study (2.5 mg/kg), the timing of s.c
injection of morphine and the differences in the behavioral
protocol do not allow us to fully compare their findings to
our study. Szczytkowski-Thomson et al. (2013), on the other
hand used a single higher dose of morphine (15 mg/kg),
which was administered immediately after a stressor to males,
but it did not reduce the fear response. In the same study,
repeated morphine doses (7.5 mg/kg) cause a decrease in fear
(Szczytkowski-Thomson et al., 2013). We decided not to treat
repeatedly with morphine due to dependence and withdrawal
issues, as we wanted to maintain a clinically relevant study.
Our current model was designed considering the translational
potential of morphine as a treatment to lower the possibilities
of trauma-related symptoms manifestation, but without creating
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FIGURE 2 | Ratio of mu opioid receptor (MOR) changes from
control group in males, proestrus and metaestrus female rats. (A)
In males the amygdala showed an increase in MOR expression produced
by morphine (p < 0.05 compared to baseline control). (B) In proestrus
female the amygdala showed an increase in MOR expression produced
by morphine (p < 0.05). (C) In metaestrus female rats the amygdala and
periaqueductal gray (PAG) showed no significant difference in MORs
expression compared to controls.
dependence to the drug. Furthermore, there is no electric shock
after the morphine administration in our protocol and this
eliminates the possibility of morphine altering pain perception.
In addition, post-trial morphine administration using the passive
avoidance paradigm, has been shown to produce facilitation
of fear memories (Mondadori and Waser, 1979). This study
used very high doses of morphine (40 or 100 mg/kg) which
may produce withdrawal signs in animals. Unfoltunately, they
did not test females. However, we acknowledge the possibility
of a post-trial reinforcement effect (Mondadori et al., 1977;
Huston and Mueller, 1978), but we are inclined to think that
it is related to a morphine-estrous cycle interaction, since the
same behavioral outcome was not observed in males or proestrus
cycling females. This possibility requires further comparative
studies.
Western blots revealed that in response to morphine and
extinction, males and proestrus females showed an increase in the
expression of MOR in the amygdala, but this was not observed
in metaestrus females. This parallels our behavioral findings
showing that males and proestrus females had no differences in
freezing responses compared to saline controls, but metaestrus
females showed over expression of freezing. As a site of initial
acquisition of extinction, it might be expected that the BLA is also
a site of extinction consolidation. Intercalated (ITC) amygdala
neurons constitute the likely mediators of extinction because
they receive conditioned stimulus information from the BLA and
contribute inhibitory projections to the central nucleus (CEA),
the main output station of the amygdala for conditioned fear
responses (Likhtik et al., 2008). The majority of MORs are
localized in the ITCs (Likhtik et al., 2008). Therefore, we propose
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that an increase in MOR activity within the ITC might decrease
fear response levels to that of saline animals, as observed in this
study, but the presence of high ovarian hormones in females
and testosterone in males is necessary for this increase to occur.
Taken together, these results suggest that MORs plays a role in
the molecular events underlying fear extinction. However, given
the fact that proestrus and metaestrus female rats differ in their
ovarian hormone levels, it is possible that the observed behavioral
responses are also influenced by these hormonal differences.
In addition to the amygdala, opioids are released in the
ventrolateral PAG when the animals are exhibiting fear to
the conditioned stimulus during the early phases of extinction
(Parsons et al., 2010). This suggests that the opioid system
plays an important role in fear conditioning and extinction.
However, we did not see significant results in the expression
of MOR when rats were sacrificed immediately after extinction.
Two possible explanations for our results are that by the time
we sacrificed the animals (after extinction) those changes have
already occurred; or the fact that we dissected the whole PAG
instead of ventrolateral region alone thus masking what is
happening in the ventrolateral PAG per se.
In conclusion, our data suggest that females exposed to
trauma during low ovarian hormone stages could be more
vulnerable to over-expression of the traumatic memories. There
are no data in the literature regarding which brain structures
are directly involved in the estrogen-morphine interaction that
modulate fear. However, our findings are beginning to fill
this gap by providing data in two brain structures that are
known to have an important role in fear conditioning, the
PAG and the amygdala. We suggest that future studies should
address in depth the interactions of ovarian hormones and
opioid receptors activity that may lead to either protect or
exacerbate traumamemories. This study contributes to clarifying
the physiological role of morphine in memory consolidation
as one of the first providing a description at molecular
level in females and highlighting the protagonic role of the
amygdala.
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